Structure-based drug design

Current Opinion in Biotechnology

Volumn 9, Issue 4, 1998, Pages 366-369

  Amzel, L Mario ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CHEMISTRY; DRUG DESIGN; DRUG STRUCTURE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032146301     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(98)80009-8     Document Type: Article

References (57)

1. Blundell TL. Structure-base drug design. Nature. 384:1996;23-36. (6604 suppl).
2. Lybrand TP. Ligand-protein docking and rational drug design. Curr Opin Struct Biol. 5:1995;224-228.
3. Verlinde CLMJ, Hol WGJ. Structure-based drug design: progress, results and challenges. Structure. 2:1994;577-587.
4. Jackson RC. Contributions of protein structure-based drug design to cancer chemotherapy. Semin Oncol. 24:1997;164-172.
5. Wade RC. 'Flu' and structure-based drug design. Structure. 5:1997;1139-1145.
6. Appelt K, Bacquel RJ, Bartlet CA, Booth CL, Freer ST, Fuhry MA, Gehring MR, Herrmann SM, Howland EF, Janson CA. Perspective: design of enzyme inhibitors using iterative protein crystallographic analysis. J Med Chem. 34:1991;1925-1934.
7. Gordon EM, Gallop MA, Patel DV. Strategy and tactics in combinatorial organic synthesis. Applications to drug discovery. Accounts Chem Res. 29:1996;144-154.
8. Gordon EM, Barrett RW, Dower WT, Fodor SPA, Gallop MA. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies and future directions. J Med Chem. 37:1994;1385-1400.
9. Terret NK, Gardner M, Jordon D, Kobylecki RJ, Steele T. Combinatorial synthesis: the design of compound libraries and their application to drug discovery. Tetrahedron. 51:1995;8135-8173.
10. Salemme FR, Spurlino J, Bone R. Serendipity meets precision: the integration of structure-based drug design and combinatorial chemistry for efficient drug discovery. Structure. 5:1997;319-324.
11. Martin ET, Spellmeyer DC, Critchlow RE, Blaney JM. Does combinatorial chemistry obviate computer-aided drug design? Rev Comput Chem. 10:1997;75-100.
12. Pardi A. Isotope labeling for nmr studies of biomolecules. Curr Opin Struct Biol. 2:1992;832-835.
13. Dublie S. Preparation of selenomethionyl proteins for phase determination. Methods Enzymol. 276:1997;523-530.
14. Boyd J, Soffe N, Campbell I. NMR at very high fields. Structure. 2:1994;253-255.
15. Ealick SE, Walter RL. Synchroton beamlines for macromolecular crystallography. Curr Opin Struct Biol. 3:1993;725-736.
16. Pflugrath JW. Developments in X-ray detectors. Curr Opin Struct Biol. 2:1992;811-815.
17. Watenpaugh KD. Macromolecular crystallography at cryogenic temperatures. Curr Opin Struct Biol. 1:1991;1012-1015.
18. Hendrickson WA, Ogata CM. Phase determination from multiwave-length anomalous diffraction measurements. Methods Enzymol. 276:1997;494-502.
19. Bernstein FC, Koetzle TF, Williams GJB, Meyer EF, Brice MD, Rodgers JR, Kennard O, Shimanouchi T, Tasumi M. The Protein Data Bank: a computer based archival file of protein structures. J Mol Biol. 112:1997;535-542. URL: http://www.pdb/bnl.gov/.
20. Jones G, Willet P. Docking small molecules into binding sites. Curr Opin Biotechnol. 6:1995;652-656.
21. Goodford PJ. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem. 28:1985;849-857.
22. Kuntz ID, Blaney JM, Oatley SJ, Langridge R, Ferrin TE. A geometric approach to macromolecule-ligand interactions. J Mol Biol. 161:1982;269-288.
23. Van Drie JH, Weininger D, Martin YC. ALLADIN: an integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching for three-dimensional molecular structures. J Comput Aided Mol Des. 3:1989;225-254.
24. Goodsell DS, Olson AJ. Automated docking of substrates to proteins by simulated annealing. Proteins. 8:1990;195-202.
25. Dixon JS. Evaluation of the CASP2 docking section. Proteins. 1997;198-204.
26. Bohm HJ. The computer program LUDI: a new method for the de novo design of enzyme inhibitors. J Comput Aided Mol Des. 6:1992;61-78.
27. Lawrence MC, Davis PC. CLIX: a search algorithm for finding novel ligands capable of binding proteins of known three-dimensional structure. Proteins. 12:1992;31-41.
28. Nishibata Y, Itai A. Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation. J Med Chem. 36:1993;2921-2928.
29. Rotstein SH, Murcko MA. GroupBuild: a fragment-based method for de novo drug design. J Med Chem. 36:1993;1700-1710.
30. Ho CMW, Marshall GR. FOUNDATION: a program to retrieve all possible structures containing a user-defined minimum number of matching query elements from three-dimensional databases. J Comput Aided Mol Des. 7:1993;3-22.
31. Meng EC, Soichet BK, Kuntz ID. Automatic docking with grid-based energy evaluation. J Comput Chem. 13:1992;505-524.
32. Mark AE, Xu Y, Liu H, van Gunsteren WF. Rapid non-empirical approaches for estimating relative binding free energies. Acta Biochim Pol. 42:1995;525-535.
33. Nienaber VL, Mersinger LJ, Kettner CA. Structure-based understanding of ligand affinity using human thrombin as a model system. Biochemistry. 35:1996;9690-9699.
34. King BL, Vajda S, DeLisi C. Empirical free energy as a target function in docking and design: application to HIV-1 protease inhibitors. FEBS Lett. 384:1996;87-91.
35. Murphy KP, Xie D, Garcia KC, Amzel LM, Freire E. Structural energetics of peptide recognition: angiotensin II/antibody binding. Proteins. 15:1993;113-120.
36. Luque I, Gomez J, Semo N, Freire E. Structure-based thermodynamic design of peptide ligands: application to peptide inhibitors of the aspartic protease endothiapepsin. Proteins. 30:1998;74-85.
37. Bardi JS, Luque I, Freire E. Structure-based thermodynamic analysis of HIV-1 protease inhibitors. Biochemistry. 36:1997;6588-6596.
38. D'Aquino JA, Gomez J, Hilser VJ, Lee KH, Amzel LM, Freire E. The magnitude of the backbone conformational entropy change in protein folding. Proteins. 25:1996;143-156.
39. Lee KH, Xie D, Freire E, Amzel LM. Estimation of changes in side chain configurational entropy in binding and folding: general methods and application to helix formation. Proteins. 20:1994;68-84.
40. Amzel LM. Loss of translational entropy in binding, folding, and catalysis. Proteins. 28:1997;144-149.
41. Murphy KP, Xie D, Thompson KS, Amzel LM, Freire E. Entropy in biological binding processes: estimation of translational entropy loss. Proteins. 18:1994;63-67.
42. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 234:1993;779-815.
43. Havel TF, Snow ME. A new method for building protein conformations from sequence alignments with homologues of known structure. J Mol Biol. 217:1991;1-7.
44. Sutcliffe MJ, Haneef I, Carney D, Blundell TL. Knowledge based modelling of homologous proteins, Part I: three-dimensional frameworks derived from the simultaneous superposition of multiple structures. Prot Eng. 1:1987;377-384.
45. Levitt M. Accurate modeling of protein conformation by automatic segment matching. J Mol Biol. 226:1992;507-533.
46. Amzel LM. Modeling the variable region of immunoglobins. Immunomethods. 1:1992;91-95.
47. Snow ME, Amzel LM. Calculating three-dimensional changes in protein structure due to amino-acid substitutions: the variable region of immunoglobulins. Proteins. 1:1986;267-279.
48. Prigge ST, Boyington JC, Gaffney BJ, Amzel LM. Structure conservation in lipoxygenases: structural analysis of soybean lipoxygenase-1 and modeling of human lipoxygenases. Proteins. 24:1996;275-291.
49. Moult J, Hubbard T, Bryant SH, Fidelas K, Pedersen JT. Critical assessment of methods of protein structure. Proteins. 1997;2-6.
50. Scherler GFX. Overproduction of membrane proteins. Curr Opin Struct Biol. 2:1992;534-544.
51. Garcia KC, Ronco PM, Verroust PJ, Brunger AT, Amzel LM. Three-dimensional structure of an angiotensin II-Fab complex at 3 rA: hormone recognition by an anti-iditypic antibody. Science. 257:1992;502-507.
52. Wolff ME, McPherson A. Antibody-directed drug discovery. Nature. 345:1990;365-366.
53. Rusinko A III. Commercially available databases of three-dimensional molecular structures. Chem Des Auto News. 8:1993;44-47.
54. Allen FH, Kennard O. 3D search and research using the Cambridge Structural Database. Chem Des Auto News. 8:1993;31-37.
55. Pearlman RS. Rapid generation of high quality approximate 3-D molecular structures. Chem Des Auto News. 2:1987;5-6.
56. Fisanick W, Cross KP, Forman JC, Rusinko A III. Experimental system for similarity and 3D searching of CAS registry substances. 1. 3D substructure searching. J Chem Int Comput Sci. 33:1993;548-559.
57. Joyce GF, Still WC, Chapman KT. Combinational chemistry. Searching for a winning combination. Curr Opin Chem Biol. 1:1997;3-4.